Hosseini Hedayat Allah, Ahani Ali, Galehdari Hamid, Froughmand Ali Mohammad, Hosseini Masoud, Masjedizadeh Abdolrahim, Zali Mohammad Reza
Biochemistry Department, Ahwaz Jondishapoor University of Medical Science, Ahwaz, Iran.
World J Gastroenterol. 2007 Jun 28;13(24):3354-8. doi: 10.3748/wjg.v13.i24.3354.
To study the loss of heterozygosity (LOH) at 8p21-23 locus in diffuse gastric cancer.
To evaluate the involvement of this region in gastric cancer, we used eight microsatellite markers covering two Mb of mentioned region, to perform a high-resolution analysis of allele loss in 42 cases of late diffuse gastric adenocarcinoma.
Six of these STS makers: D8S1149, D8S1645, D8S1643, D8S1508, D8S1591, and D8S1145 showed 36%, 28%, 37%, 41%, 44% and 53% LOH, respectively.
A critical region of loss, close to the NAT2 locus and relatively far from FEZ1 gene currently postulated as tumor suppressor gene in this region.
研究弥漫性胃癌8p21 - 23位点的杂合性缺失(LOH)。
为评估该区域在胃癌中的累及情况,我们使用了覆盖上述区域2兆碱基的8个微卫星标记,对42例晚期弥漫性胃腺癌进行等位基因缺失的高分辨率分析。
其中6个序列标签位点(STS)标记:D8S1149、D8S1645、D8S1643、D8S1508、D8S1591和D8S1145的杂合性缺失分别为36%、28%、37%、41%、44%和53%。
一个关键的缺失区域,靠近目前假定为该区域肿瘤抑制基因的NAT2位点且相对远离FEZ1基因。